Utama › Kanser Laring
Kajian klinikal Kanser Laring sedang mengambil peserta di AS
26 kajian untuk Kanser Laring sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Milwaukee, WI8 kajian
- Atlanta, GA8 kajian
- Chicago, IL8 kajian
- Kansas City, MO7 kajian
- St. Louis, MO7 kajian
- Edison, NJ6 kajian
- Pittsburgh, PA6 kajian
- Durham, NC6 kajian
- Portland, OR6 kajian
- Baltimore, MD6 kajian
- Cincinnati, OH6 kajian
- Richmond, VA6 kajian
- New York City, NY5 kajian
- Queens, NY5 kajian
- Kansas City, KS5 kajian
- Naperville, IL5 kajian
- Omaha, NE5 kajian
- Philadelphia, PA5 kajian
- Oklahoma City, OK5 kajian
- Ann Arbor, MI5 kajian
- Champaign, IL5 kajian
- Charleston, IL5 kajian
- Danville, IL5 kajian
- Overland Park, KS5 kajian
- Irvine, CA5 kajian
- Cedar Rapids, IA5 kajian
- Duluth, MN5 kajian
- Fargo, ND5 kajian
- Lansing, MI5 kajian
- Stevens Point, WI5 kajian
- Joliet, IL5 kajian
- Peoria, IL5 kajian
- Bloomington, IL5 kajian
- Wausau, WI5 kajian
- Cape Girardeau, MO5 kajian
- O'Fallon, MO4 kajian
- Erie, PA4 kajian
- Des Moines, IA4 kajian
- Los Angeles, CA4 kajian
- Little Rock, AR4 kajian
Mengikut negeri
- Arizona5 kajian
- Arkansas5 kajian
- California9 kajian
- Colorado7 kajian
- Connecticut3 kajian
- Delaware3 kajian
- Florida8 kajian
- Georgia8 kajian
- Idaho4 kajian
- Illinois9 kajian
- Indiana4 kajian
- Iowa8 kajian
- Kansas7 kajian
- Kentucky3 kajian
- Louisiana4 kajian
- Maryland7 kajian
- Massachusetts7 kajian
- Michigan6 kajian
- Minnesota7 kajian
- Mississippi3 kajian
- Missouri9 kajian
- Montana5 kajian
- Nebraska5 kajian
- New Hampshire3 kajian
- New Jersey7 kajian
- New Mexico3 kajian
- New York10 kajian
- North Carolina8 kajian
- North Dakota5 kajian
- Ohio11 kajian
- Oklahoma6 kajian
- Oregon6 kajian
- Pennsylvania9 kajian
- South Carolina5 kajian
- South Dakota3 kajian
- Tennessee3 kajian
- Texas5 kajian
- Virginia7 kajian
- Washington3 kajian
- Wisconsin9 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06589804Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06997068Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07195734BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05136196Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06980038Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT05172245Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT02734537Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07156227Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT07441681Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jul 2026 · NCT06662058Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Jul 2026 · NCT01365169Integrated Cancer Repository for Cancer Research
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 19 hingga 110 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT02012699Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Apr 2026 · NCT07209189Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Apr 2026 · NCT03010150TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Mac 2026 · NCT06868433A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Feb 2026 · NCT07063212Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Feb 2026 · NCT06636734Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Feb 2026 · NCT01473784CONFIRM: Magnetic Resonance Guided Radiation Therapy
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Feb 2026 · NCT04368702Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Dis 2025 · NCT05793151Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Nov 2025 · NCT06080503SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
Mengambil pesertaFasa awal 1
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Okt 2025 · NCT06914999Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Mengambil pesertaKajian pemerhatian
Umur 21 hingga 90 · Semua jantina · Dikemas kini 22 Sep 2025 · NCT00900419Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.